In the News… More T2D predicted, Basal-only pump planned, Glucagon discontinued.. and more!
It’s In the News, a look at the top stories from the diabetes community from the last seven days. This week: predictions of a huge increases in cases of type 2, insulin prices are capped for those with Medicare, Omnipod commits to a basal-only pump for people with type 2, and more! In the news…